Immunoprecipitation Market Research Report Information by Type (Individual Immunoprecipitation, Co-Immunoprecipitation, Chromatin Immunoprecipitation, and RNA Immunoprecipitation), Product (Kit, Reagent, others), End-User (CROs, others) - Forecast till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Immunoprecipitation Market, by Type

6.1 Introduction

6.2 Individual Immunoprecipitation

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Co-Immunoprecipitation

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4 Chromatin Immunoprecipitation

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5 RNA Immunoprecipitation

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Immunoprecipitation Market, by Product

7.1 Introduction

7.2 Kit

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Reagent

7.3.1 Antibodies

7.3.1.1 Primary

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3.1.2 Secondary

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3.2 Beads

7.3.2.1 Agarose Beads

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3.2.2 Magnetic Beads

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3.2.3 Buffers

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8. Global Immunoprecipitation Market, by End User

8.1 Introduction

8.2 Pharmaceutical & Biotechnology Companies

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Academic & Research Institutes

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Contract Research Organizations

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9. Global Immunoprecipitation Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Abcam plc

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 GenScript

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 THERMO FISHER SCIENTIFIC

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Bio-Rad Laboratories, Inc.

11.4.1 Company Overview

11.4.2 Type Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Merck KGaA

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 BioLegend, Inc.

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Takara Bio Inc.

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Rockland Immunochemicals Inc.

11.8.1 Overview

11.8.2 Type Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Cell Signaling Technology, Inc.

11.9.1 Overview

11.9.2 Type Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Geno Technology Inc.

11.10.1 Overview

11.10.2 Type Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Immunoprecipitation Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Immunoprecipitation Market Synopsis, 2020–2027

Table 2 Global Immunoprecipitation Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Immunoprecipitation Market, by Region, 2020–2027 (USD Million)

Table 4 Global Immunoprecipitation Market, by Type, 2020–2027 (USD Million)

Table 5 Global Immunoprecipitation Market, by Product, 2020–2027 (USD Million)

Table 6 Global Immunoprecipitation Market, by End User, 2020–2027 (USD Million)

Table 7 North America: Immunoprecipitation Market, by Type, 2020–2027 (USD Million)

Table 8 North America: Immunoprecipitation Market, by Product, 2020–2027 (USD Million)

Table 9 North America: Immunoprecipitation Market, by End User, 2020–2027 (USD Million)

Table 10 US: Immunoprecipitation Market, by Type, 2020–2027 (USD Million)

Table 11 US: Immunoprecipitation Market, by Product, 2020–2027 (USD Million)

Table 12 US: Immunoprecipitation Market, by End User, 2020–2027 (USD Million)

Table 13 Canada: Immunoprecipitation Market, by Type, 2020–2027 (USD Million)

Table 14 Canada: Immunoprecipitation Market, by Product, 2020–2027 (USD Million)

Table 15 Canada: Immunoprecipitation Market, by End User, 2020–2027 (USD Million)

Table 16 South America: Immunoprecipitation Market, by Type, 2020–2027 (USD Million)

Table 17 South America: Immunoprecipitation Market, by Product, 2020–2027 (USD Million)

Table 18 South America: Immunoprecipitation Market, by End User, 2020–2027 (USD Million)

Table 19 Europe: Immunoprecipitation Market, by Type, 2020–2027 (USD Million)

Table 20 Europe: Immunoprecipitation Market, by Product, 2020–2027 (USD Million)

Table 21 Europe: Immunoprecipitation Market, by End User, 2020–2027 (USD Million)

Table 22 Western Europe: Immunoprecipitation Market, by Type, 2020–2027 (USD Million)

Table 23 Western Europe: Immunoprecipitation Market, by Product, 2020–2027 (USD Million)

Table 24 Western Europe: Immunoprecipitation Market, by End User, 2020–2027 (USD Million)

Table 25 Eastern Europe: Immunoprecipitation Market, by Type, 2020–2027 (USD Million)

Table 26 Eastern Europe: Immunoprecipitation Market, by Product, 2020–2027 (USD Million)

Table 27 Eastern Europe: Immunoprecipitation Market, by End User, 2020–2027 (USD Million)

Table 28 Asia-Pacific: Immunoprecipitation Market, by Type, 2020–2027 (USD Million) Table 29 Asia-Pacific: Immunoprecipitation Market, by Product, 2020–2027 (USD Million)

Table 30 Asia-Pacific: Immunoprecipitation Market, by End User, 2020–2027 (USD Million)

Table 31 Middle East & Africa: Immunoprecipitation Market, by Type, 2020–2027 (USD Million)

Table 32 Middle East & Africa: Immunoprecipitation Market, by Product, 2020–2027 (USD Million)

Table 33 Middle East & Africa: Immunoprecipitation Market, by End User, 2020–2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Immunoprecipitation Market

Figure 3 Market Dynamics for Global Immunoprecipitation Market

Figure 4 Global Immunoprecipitation Market Share, by Type, 2020

Figure 5 Global Immunoprecipitation Market Share, by Product, 2020

Figure 6 Global Immunoprecipitation Market Share, by End User, 2020

Figure 7 Global Immunoprecipitation Market Share, by Region, 2020

Figure 8 North America: Immunoprecipitation Market Share, by Country, 2020

Figure 9 Europe: Immunoprecipitation Market Share, by Country, 2020

Figure 10 Asia-Pacific: Immunoprecipitation Market Share, by Country, 2020

Figure 11 Middle East & Africa: Immunoprecipitation Market Share, by Country, 2020

Figure 12 Global Immunoprecipitation Market: Company Share Analysis, 2020 (%)

Figure 13 Abcam plc: Key Financials

Figure 14 Abcam plc: Segmental Revenue

Figure 15 Abcam plc: Geographical Revenue

Figure 16 GenScript: Key Financials

Figure 17 GenScript: Segmental Revenue

Figure 18 GenScript: Geographical Revenue

Figure 19 Thermo Fisher Scientific: Key Financials

Figure 20 Thermo Fisher Scientific: Segmental Revenue

Figure 21 Thermo Fisher Scientific: Geographical Revenue

Figure 22 Bio-Rad Laboratories, Inc.: Key Financials

Figure 23 Bio-Rad Laboratories, Inc.: Segmental Revenue

Figure 24 Bio-Rad Laboratories, Inc.: Geographical Revenue

Figure 25 Merck KGaA: Key Financials

Figure 26 Merck KGaA: Segmental Revenue

Figure 27 Merck KGaA: Geographical Revenue

Figure 28 BioLegend, Inc.: Key Financials

Figure 29 BioLegend, Inc.: Segmental Revenue

Figure 30 BioLegend, Inc.: Geographical Revenue

Figure 31 Takara Bio Inc.: Key Financials

Figure 32 Takara Bio Inc.: Segmental Revenue

Figure 33 Takara Bio Inc.: Geographical Revenue

Figure 34 Rockland Immunochemicals Inc.: Key Financials

Figure 35 Rockland Immunochemicals Inc.: Segmental Revenue

Figure 36 Rockland Immunochemicals Inc.: Geographical Revenue

Figure 37 Cell Signaling Technology, Inc.: Key Financials

Figure 38 Cell Signaling Technology, Inc.: Segmental Revenue

Figure 39 Cell Signaling Technology, Inc.: Geographical Revenue

Figure 40 Geno Technology Inc.: Key Financials

Figure 41 Geno Technology Inc.: Segmental Revenue

Figure 42 Geno Technology Inc.: Geographical Revenue